1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (6438)
  2. Meeting Abstract (5172)
  3. Review (332)
  4. Book Section (310)
  5. Editorial (92)
  6. Research Letter (73)
  7. Guidelines (52)
  8. Correspondence (47)
  9. Conference Paper (38)
  10. Miscellaneous (37)
  11. Book Whole (24)
Groups
  1. Department of Pathology and Laboratory Medicine (12615)
  2. GSK Faculty (4773)
  3. Department of Medicine (4722)
  4. Surgery (3639)
  5. Solid Tumor Oncology Division (3422)
  6. Human Oncology and Pathogenesis Program (3037)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Victor Reuter (1228)
  3. Cristina Antonescu (895)
  4. Michael Berger (765)
  5. William Travis (743)
  6. Jinru Shia (719)

More People

Years
  1. 2025 (307)
  2. 2024 (719)
  3. 2023 (766)
  4. 2022 (841)
  5. 2021 (677)
  6. 2020 (787)

More Years

Publications
  1. Laboratory Investigation (1448)
  2. Modern Pathology (1440)
  3. Journal of Clinical Oncology (863)
  4. American Journal of Surgical Pathology (429)
  5. Cancer Research (426)
  6. Blood (349)

More Publications

Publishers
  1. Nature Publishing Group (1939)
  2. Nature Research (1457)
  3. Elsevier Inc. (1139)
  4. American Society of Clinical Oncology (955)
  5. American Association for Cancer Research (923)
  6. Lippincott Williams & Wilkins (896)

More Publishers

Results (12615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Next-generation sequencing of genomic and cDNA to identify a high frequency of kinase fusions involving ROS1, ALK, RET, NTRK1, and BRAF in Spitz tumors
    Meeting Abstract

    Stephens, P.; Wiesner, T.; He, J.; Yelensky, R.; Esteve-Puig, R.; Otto, G.; Berger, M. F.; Lipson, D.; Brennan, K.; Miller, V. A.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Genome sequencing of multiple primary tumors to reveal underlying germline cancer susceptibility
    Meeting Abstract

    Schrader, K. A.; Stratton, K. L.; Murali, R.; Laitman, Y.; Cavallone, L.; Offit, L.; Wen, Y. H.; Shah, S.; Rau-Murthy, R.; Manschreck, C.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Lymph node metastases in endocervical adenocarcinoma: Correlation with Silva pattern of invasion
    Meeting Abstract

    Rutgers, J. K. L.; Zaino, R. J.; Young, R. H.; Ronnett, B. M.; Longacre, T. A.; Alvarado-Cabrero, I.; Park, K. J.; Roma, A.; Osann, K.; Silva, E.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Response to erlotinib and prognosis for patients with de novo epidermal growth factor receptor (EGFR) T790M mutations
    Meeting Abstract

    Riely, G. J.; Yu, H. A.; Arcila, M. E.; Hellmann, M. D.; Ladanyi, M.; Kris, M. G.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A validated 34-gene signature for assessing risk of recurrence in clear cell renal cell carcinoma
    Meeting Abstract

    Rathmell, K.; Brooks, S. A.; Brannon, A. R.; Parker, J. S.; Fisher, J. C.; Sen, O.; Nielsen, M. E.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Patterns of metastasis and survival in patients with PI3K pathway-driven stage IV squamous cell lung cancers (SQCLC)
    Meeting Abstract

    Paik, P. K.; Moreira, A. L.; Wang, L.; Won, H. H.; Hasanovic, A.; Rekhtman, N.; Sima, C. S.; Ladanyi, M.; Berger, M. F.; Kris, M. G.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Randomized phase II study of gemcitabine (G), cisplatin (C) with or without veliparib (V) (arms A, B) and a phase II single-arm study of single-agent veliparib (arm C) in patients with BRCA or PALB2-mutated pancreas adenocarcinoma (PC)
    Meeting Abstract

    O'Reilly, E. M.; Lowery, M. A.; Yu, K. H.; Capanu, M.; Stadler, Z. K.; Epstein, A. S.; Golan, T.; Segal, A.; Segal, M.; Salo-Mullen, E. E.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Characterization of colorectal cancer (CRC) in Lynch syndrome (LS) patients with MSH6 or PMS2 mutations
    Meeting Abstract

    Lee, J. K.; Shia, J.; Rau-Murthy, R.; Corines, M.; Salo-Mullen, E. E.; Markowitz, A.; Robson, M. E.; Offit, K.; Guillem, J. G.; Saltz, L.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • The CAP-IASLC-AMP molecular testing guideline for the selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors
    Meeting Abstract

    Ladanyi, M.; Cagle, P. T.; Beasley, M. B.; Chitale, D.; Dacic, S.; Giaccone, G.; Jenkins, R. B.; Kwiatkowski, D. J.; Saldivar, J. S.; Squire, J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase Ib/II study of imatinab and everolimus in patients with PDGFRA plus synovial sarcoma
    Meeting Abstract

    Keohan, M. L.; Tap, W. D.; Dickson, M. A.; D'Angelo, S. P.; Carvajal, R. D.; Gounder, M. M.; Morales, R. E.; Condy, M. M.; Hameed, M.; Ho, A. L.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save